IL1B and cancer: LAB treatment increased IL-1β secretion in tumour tissue whereby the DMH+P group (460.2 ± 53.5 pg/mL) was higher than those in the cancer control (401.1 ± 56.9 pg/mL), but without statistical significance (Figure 3a).